Overview
Bayer Links
Investor Relations
Cover picture
Bayer: Science For A Better Life
Bayer chemists Dr. Susanne Roehrig and Dr. Alexander Straub examine the molecular contours of rivaroxaban – the active ingredient of the new anticoagulant 
Xarelto® – using a computer simulation. One of Bayer‘s aims in developing this innovative drug is to minimize the risk of thrombosis following orthopedic surgery. Read more in the magazine section.
Xarelto® – using a computer simulation. One of Bayer‘s aims in developing this innovative drug is to minimize the risk of thrombosis following orthopedic surgery. Read more in the magazine section.
Bookmark this page
E-mail this page
Advanced Search
